Status:

NOT_YET_RECRUITING

The REmission of Diabetes Using a PlAnt-based Weight Loss InteRvention (REPAIR) Trial

Lead Sponsor:

University of Toronto

Collaborating Sponsors:

Unity Health Toronto

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to learn if a plant-based intensive lifestyle intervention can achieve remission of diabetes. It will also learn if a plant-based intensive lifestyle intervention ca...

Eligibility Criteria

Inclusion

  • Age of 18 years;
  • Equal number of males and females;
  • Obese (body mass index \[BMI\] and waist circumference using sex and ethnic-specific thresholds for obesity and significant abdominal adiposity);
  • Diagnosed with type 2 diabetes within the last 6 years;
  • Treated by non-insulin antihyperglycemic therapy;
  • Have an HbA1c 6.0-10.0%;
  • Taking a stable dose of antihypertensive, antihyperglycemic, or antihyperlipidemic medications for ≥3-months, if applicable;
  • Have a family physician and an Ontario Health Card;

Exclusion

  • Type 1 diabetes;
  • HbA1c \<6.0% or \>10%;
  • Recent weight loss (≥5 kg) in the last 6 months;
  • Treated with diet alone;
  • Treated with insulin;
  • Treated with GLP-1/GIP/glucagon receptor agonist therapies;
  • Treated with other anti-obesity drugs;
  • Eating disorder, substance abuse disorder, serious depression, psychiatric disorder;
  • Allergy or intolerance to soy;
  • Allergy or intolerance to peanuts, tree nuts and seeds (all three);
  • Pregnant or intending pregnancy;
  • Currently breastfeeding;
  • Bariatric or surgery in the last 6 months;
  • Major cardiovascular event in the last 6 months;
  • Kidney dysfunction;
  • Unstable or severe heart failure;
  • Major illness or chronic infection;
  • Atherosclerotic cardiovascular disease (ASCVD);
  • Chronic kidney disease (CKD);
  • Treated for cancer in the last 12 months;
  • Participating in another trial;
  • Told by a doctor to refrain from physical activity;
  • Any condition that would prevent you from following study procedures;
  • Family physician does not consent to your participation

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2029

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT06906172

Start Date

September 1 2025

End Date

December 30 2029

Last Update

April 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unity Health Toronto (St. Michael's Hospital)

Toronto, Ontario, Canada